Currently Viewing:
Newsroom
Currently Reading
Large Review Finds Vitamin D Ineffective in Preventing Fractures, Falls
October 15, 2018 – Allison Inserro
Driver Mutations May Predict Patient Outcomes in Myeloproliferative Neoplasms
October 15, 2018 – Kelly Davio
Three Genetic Types Drive Higher Prevalence of MM in African Americans
October 14, 2018 – Laura Joszt
ACOs Had No Significant Impact on Spending for Patients With Cancer
October 14, 2018 – Laura Joszt
Analysis Estimates Empagliflozin Will Add Years to Life for People With Type 2 Diabetes
October 13, 2018 – Mary Caffrey
Study Examines Impact of Deviating From NCCN Guidelines for Metastatic Breast Cancer
October 13, 2018 – Allison Inserro
Researchers Have Found 3 Genes Linked to Chronic Back Pain
October 12, 2018 – Allison Inserro
FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval
October 12, 2018 – Allison Inserro
Know the Risk: 5 Breast Cancer Risk Factors
October 12, 2018 – Samantha DiGrande

Cardiovascular Conditions Common in Both Patients With Demyelinating Diseases and Unaffected Individuals, Study Finds

Alison Rodriguez
A recent study aimed to evaluate the burden of age of onset of cardiovascular conditions in a US population with multiple sclerosis, neuromyelitis optica spectrum disorder, or transverse myelitis and found that cardiovascular conditions are as common in those with demyelinating diseases compared with unaffected individuals.
Patients who suffer from cardiovascular conditions often face poorer outcomes with multiple sclerosis (MS). A recent study aimed to evaluate the burden of age of onset of cardiovascular conditions in a US population with MS, neuromyelitis optica spectrum disorder (NMOSD), or transverse myelitis (TM) and found that cardiovascular conditions are as common in those with demyelinating diseases compared with unaffected individuals.

“MS, NMOSD, and TM are autoimmune, demyelinating diseases of the central nervous system with heterogeneous clinical presentations that adversely impact daily functioning, employment, and quality of life,” explained the study. “These inflammatory, demyelinating conditions do have distinct immunopathogenesis, epidemiology, and clinical phenotypes.”

The researchers recruited patients from the Accelerated Cure Project Repository, an open-access collection of blood-derived biological samples and epidemiologic data from individuals with MS, NMOSD, TM, and other rare demyelinating diseases, as well as unaffected controls. The data collected were then used to compare the burden of self-reported type 2 diabetes, heart disease, hyperlipidemia, and hypertension in individuals with MS, NMOSD, and TM with that among controls. The data were adjusted for demographics, smoking history, obesity, family history of individual cardiovascular conditions, and presence of cardiovascular conditions.

In total there were 1548 MS cases, 306 NMOSD cases, 145 TM cases, and 677 unaffected controls included in the analysis. The main findings revealed that patients with MS were 48% more likely to have ever had hypertension than controls, but this association was independent of established cardiovascular risk factors, such as smoking history and obesity. Additionally, there were no differences in the age of cardiovascular disease onset between cases and control subjects.

“It is also important to acknowledge evidence suggesting hypertension may be a side effect of various disease-modifying therapies,” noted the authors. “Nonetheless, the age of hypertension onset did not differ between all MS cases and controls, which may suggest a modest role for disease modifying therapies on hypertension risk in these MS cases.”

The authors emphasized the need to include comorbidity management as part of care for patients with demyelinating disease, in addition to new collaborative models of care, in order to improve the treatment of patients.

“In summary, this study demonstrates the burden of cardiovascular conditions are similar, in persons with demyelinating diseases as they are in unaffected individuals, with the exception of hypertension being more common in those with MS even after accounting of established cardiovascular risk factors,” concluded the researchers. “Considering prior studies connecting cardiovascular conditions with adverse MS outcomes, one can hypothesize that optimization of cardiac comorbidities may result in a less severe outcomes for those with MS, and by extension NMOSD and TM.”

Reference

Saroufim P, Zweig S, Conway DS, Briggs FBS. Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis [published online July 10, 2018]. Mult Scler Relat Disord. doi: 10.1016/j.msard.2018.07.011.

Related Articles

Studies Evaluate Effects of Secondary Progressive Multiple Sclerosis
Patients With Multiple Sclerosis Need Better Dietary Education From Providers
Individuals With HIV Are Twice as Likely to Develop Cardiovascular Disease, Study Finds
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!